Results 151 to 160 of about 506,611 (220)

Phylogenetic analysis of serotype 19A-sequence type (ST)2331 <i>Streptococcus pneumoniae</i> associated with the Pneumococcal Molecular Epidemiology Network (PMEN)34 clone predominant in Japan after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). [PDF]

Microb Genom
Koide S, Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Sugawara Y, Akeda Y, Sugai M.   +8 more
europepmc   +1 more source

Cost-effectiveness and budget impact analyses of the 24-valent pneumococcal conjugate vaccine in adults aged 50 and older. [PDF]

Vaccine
Altawalbeh SM, Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ.   +7 more
europepmc   +1 more source

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics. [PDF]

Front Public Health
Petrutienė A, Sinotova J, Pupienienė N, Marcinonytė R, Padvilikytė I, Razmuk J, Muralytė S, Bulavaitė A, Plečkaitytė M.   +8 more
europepmc   +1 more source

Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review. [PDF]

Hum Vaccin Immunother
Shono A, Hoshi SL, Kondo M.
europepmc   +1 more source

Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review. [PDF]

Infect Dis Ther
Dunne EM, Hong L, Althouse BM, Hayford K, Jodar L, Gessner BD, Theilacker C.   +6 more
europepmc   +1 more source

Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial. [PDF]

N Engl J Med
Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG.   +20 more
europepmc   +1 more source

Effectiveness of the 13-valent pneumococcal conjugate vaccine against medically attended pneumococcal lower respiratory tract infection among older adults: a case-control study. [PDF]

Sci Rep
Ngamprasertchai T, Phatharodom P, Intalapaporn K, Sutthipool K, Chongtrakool P, Yungyuen T, Luvira V, Ratanasuwan W, Rattanaumpawan P, Lawpoolsri S, Pitisuttithum P.   +10 more
europepmc   +1 more source

Eighteen-Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media During the Pneumococcal Conjugate Vaccine Era, 2006-2023. [PDF]

J Infect Dis
Fuji N, Salamone FN, Kaur R, Bajorski P, Gonzalez E, Wang L, Ali M, Miller A, Grant LR, Arguedas A, Pichichero ME.   +10 more
europepmc   +1 more source

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
Ngamprasertchai T, Ruenroengbun N, Kajeekul R.   +2 more
europepmc   +1 more source

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
europepmc   +1 more source